|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Walboomers JM, Jacobs MV, Manos MM, et al:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Munoz N, Bosch FX, de Sanjose S, et al:
Epidemiologic classification of human papillomavirus types
associated with cervical cancer. N Engl J Med. 348:518–527. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Clifford GM, Smith JS, Plummer M, Munoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: a meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Munger K and Howley PM: Human
papillomavirus immortalization and transformation functions. Virus
Res. 89:213–228. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Kano M, Seki N, Kikkawa N, et al: miR-145,
miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in
esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Moriya Y, Nohata N, Kinoshita T, et al:
Tumor suppressive microRNA-133a regulates novel molecular networks
in lung squamous cell carcinoma. J Hum Genet. 57:38–45. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hidaka H, Seki N, Yoshino H, et al: Tumor
suppressive microRNA-1285 regulates novel molecular targets:
aberrant expression and functional significance in renal cell
carcinoma. Oncotarget. 3:44–57. 2012.
|
|
11.
|
Ichimi T, Enokida H, Okuno Y, et al:
Identification of novel microRNA targets based on microRNA
signatures in bladder cancer. Int J Cancer. 125:345–352. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kojima S, Chiyomaru T, Kawakami K, et al:
Tumour suppressors miR-1 and miR-133a target the oncogenic function
of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J
Cancer. 106:405–413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kikkawa N, Hanazawa T, Fujimura L, et al:
miR-489 is a tumour-suppressive miRNA target PTPN11 in
hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer.
103:877–884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Nohata N, Hanazawa T, Kikkawa N, et al:
Tumour suppressive microRNA-874 regulates novel cancer networks in
maxillary sinus squamous cell carcinoma. Br J Cancer. 105:833–841.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yamamoto N, Kinoshita T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
16.
|
Wang Y, Zhang X, Li H, Yu J and Ren X: The
role of miRNA-29 family in cancer. Eur J Cell Biol. 92:123–128.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Li Y, Wang F, Xu J, et al: Progressive
miRNA expression profiles in cervical carcinogenesis and
identification of HPV-related target genes for miR-29. J Pathol.
224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Mott JL, Kurita S, Cazanave SC, Bronk SF,
Werneburg NW and Fernandez-Zapico ME: Transcriptional suppression
of miR-29b-l/miR-29a promoter by c-Myc, hedgehog, and NF-kappaB. J
Cell Biochem. 110:1155–1164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wang H, Garzon R, Sun H, et al:
NF-kappaB-YYl-miR-29 regulatory circuitry in skeletal myogenesis
and rhabdomyosarcoma. Cancer Cell. 14:369–381. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Nagata K, Saga S and Yamada KM:
Characterization of a novel transformation-sensitive heat-shock
protein (HSP47) that binds to collagen. Biochem Biophys Res Commun.
153:428–434. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Nagai N, Tetuya Y, Hosokawa N and Nagata
K: The human genome has only one functional hsp47 gene (CBP2) and a
pseudogene (pshsp47). Gene. 227:241–248. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Ishida Y and Nagata K: Hsp47 as a
collagen-specific molecular chaperone. Methods Enzymol.
499:167–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sauk JJ, Nikitakis N and Siavash H: Hsp47
a novel collagen binding serpin chaperone, autoantigen and
therapeutic target. Front Biosci. 10:107–118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Hubmacher D and Apte SS: The biology of
the extracellular matrix: novel insights. Curr Opin Rheumatol.
25:65–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kriegel AJ, Liu Y, Fang Y, Ding X and
Liang M: The miR-29 family: genomics, cell biology, and relevance
to renal and cardiovascular injury. Physiol Genomics. 44:237–244.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Maitra A, Iacobuzio-Donahue C, Rahman A,
et al: Immunohistochemical validation of a novel epithelial and a
novel stromal marker of pancreatic ductal adenocarcinoma identified
by global expression microarrays: sea urchin fascin homolog and
heat shock protein 47. Am J Clin Pathol. 118:52–59. 2002.
View Article : Google Scholar
|
|
28.
|
Hirai K, Kikuchi S, Kurita A, et al:
Immunohistochemical distribution of heat shock protein 47 (HSP47)
in scirrhous carcinoma of the stomach. Anticancer Res. 26:71–78.
2006.PubMed/NCBI
|
|
29.
|
Lee SS, Tseng LH, Li YC, Tsai CH and Chang
YC: Heat shock protein 47 expression in oral squamous cell
carcinomas and upregulated by arecoline in human oral epithelial
cells. J Oral Pathol Med. 40:390–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Jing Y, Han Z, Zhang S, Liu Y and Wei L:
Epithelial-mesenchymal transition in tumor microenvironment. Cell
Biosci. 1:292011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013.PubMed/NCBI
|
|
32.
|
Gebeshuber CA, Zatloukal K and Martinez J:
miR-29a suppresses tristetraprolin, which is a regulator of
epithelial polarity and metastasis. EMBO Rep. 10:400–405. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Shintani Y, Fukumoto Y, Chaika N, Svoboda
R, Wheelock MJ and Johnson KR: Collagen I-mediated up-regulation of
N-cadherin requires cooperative signals from integrins and
discoidin domain receptor 1. J Cell Biol. 180:1277–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Shintani Y, Maeda M, Chaika N, Johnson KR
and Wheelock MJ: Collagen I promotes epithelial-to-mesenchymal
transition in lung cancer cells via transforming growth factor-beta
signaling. Am J Respir Cell Mol Biol. 38:95–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
